Wegovy cost without insurance (2026 guide)

Wegovy’s list price is about $1,350 for a 28-day supply. That’s $16,200 per year for a medication most people need to take indefinitely. If you’re paying out of pocket, those numbers are hard to stomach. But the sticker price isn’t always what you’ll actually pay. Between manufacturer savings programs, pharmacy discount platforms, and compounded semaglutide alternatives, the real cost ranges from $149 to $1,350 per month depending on which route you take.

This guide breaks down every option available in 2026, with actual prices and eligibility requirements. If you’re exploring GLP-1 medications for weight loss, knowing what you’ll actually pay matters before you commit.

Quick pricing comparison

Option	Monthly cost	Semaglutide type	Prescription required	Notes
Wegovy retail (no insurance)	~$1,350	Brand-name (Novo Nordisk)	Yes	List price at most pharmacies
Wegovy with savings card (commercial insurance)	$25	Brand-name	Yes	Max $100/mo savings; excludes government insurance
Wegovy self-pay (NovoCare Pharmacy)	$149-$349	Brand-name	Yes	$149-$199 intro pricing on select doses; $349 ongoing
GoodRx / pharmacy coupons	$199-$349	Brand-name	Yes	Introductory pricing for first 2 fills
Compounded semaglutide (telehealth)	$149-$299	Compounded (503A/503B pharmacy)	Yes	Includes provider visit and supplies at most clinics
Ozempic (off-label)	~$950-$1,100	Brand-name (Novo Nordisk)	Yes	FDA-approved for diabetes, not weight loss

What Wegovy actually costs at the pharmacy

The wholesale acquisition cost (WAC) for Wegovy is approximately $1,349.02 for a single 28-day pen, regardless of dose strength [1]. That price applies whether you’re on the 0.25 mg starter dose or the full 2.4 mg maintenance dose.

In practice, retail pharmacy prices vary slightly. GoodRx reports cash prices averaging around $1,623 before discounts [1]. The variation depends on your pharmacy, location, and whether any markups apply.

Here’s what makes this especially painful: Wegovy is designed for long-term use. The STEP 1 trial extension showed that participants regained about two-thirds of lost weight within a year of stopping the medication [2]. So you’re not looking at a 6-month expense. For most people, this is an ongoing cost.

Novo Nordisk savings programs

Novo Nordisk runs several programs that can dramatically reduce what you pay. The catch is that eligibility varies, and the programs change frequently.

Wegovy savings card (for commercially insured patients)

If you have commercial health insurance that covers Wegovy, the manufacturer savings card brings your copay down to as little as $25 per month, with a maximum savings of $100 per 1-month fill [3]. Government insurance (Medicare, Medicaid, Tricare) is excluded entirely.

NovoCare Pharmacy self-pay pricing

For patients without insurance coverage for Wegovy, Novo Nordisk offers direct pricing through NovoCare Pharmacy. As of early 2026, these prices apply [3]:

• Starter doses (0.25 mg, 0.5 mg): $199/month for first 2 fills (introductory offer valid through June 30, 2026)
• Mid-range doses (1.5 mg, 4 mg tablets): $149/month introductory pricing (4 mg offer available through August 31, 2026, then $199/month)
• All doses after intro period: $349/month for injections, $299/month for oral tablets

These prices require ordering through NovoCare Pharmacy specifically. Your regular pharmacy won’t match them.

GoodRx and pharmacy discount cards

GoodRx offers introductory pricing of $199 per month for the first two injection fills and $149 per month for certain pill doses [1]. After that, ongoing pricing is $349 per month for injections and $299 for tablets. These aren’t insurance. They’re negotiated discount rates available at participating pharmacies.

The math still isn’t great for long-term use. Even at $349 per month, you’re paying $4,188 per year. Better than $16,200, but not exactly cheap.

Compounded semaglutide: the most affordable option

For many patients paying out of pocket, compounded semaglutide is the most practical path to GLP-1 treatment. Compounded versions contain the same active ingredient but are prepared by licensed compounding pharmacies (503A or 503B) rather than manufactured by Novo Nordisk.

Most telehealth providers offering compounded semaglutide charge between $149 and $299 per month, and that price typically includes the provider consultation, medication, and supplies [4]. Some programs run as low as $74-$129 per month for lower doses.

How compounded semaglutide compares to Wegovy

The active molecule is the same: semaglutide. The difference is in manufacturing, formulation, and regulatory oversight.

Wegovy is FDA-approved, manufactured under strict GMP conditions, and has been tested in large clinical trials involving over 16,000 participants across the STEP program [5]. You know exactly what’s in each pen.

Compounded semaglutide is not FDA-approved as a finished product. Quality depends on the compounding pharmacy. 503B outsourcing facilities face more FDA oversight than 503A pharmacies, so asking your provider which type they use matters. The FDA has raised concerns about some compounded semaglutide products, particularly from less reputable sources [4].

That said, many patients tolerate compounded semaglutide well and see comparable weight loss results when properly dosed. If Wegovy’s price puts GLP-1 therapy entirely out of reach, compounded versions offer a legitimate alternative through licensed pharmacies with a valid prescription.

For more on safety considerations, see our guide on whether compounded semaglutide is safe.

Why Wegovy costs so much

Novo Nordisk has no generic competition. Semaglutide is still under patent protection, and no generic Wegovy or Ozempic exists yet. Rybelsus (oral semaglutide for diabetes) is also brand-only.

The company has made some pricing concessions. In late 2025, Novo Nordisk launched the NovoCare Pharmacy program with reduced self-pay pricing. But even at $349 per month, the price reflects a monopoly position in a market where demand far exceeds what insurance will cover.

Insurance coverage for weight loss medications remains inconsistent. Some commercial plans cover Wegovy, especially after its 2024 FDA approval for cardiovascular risk reduction in adults with obesity [6]. But many plans still categorize it as a “lifestyle” medication and exclude it. Medicare Part D began limited coverage in 2026 for certain qualifying conditions, but restrictions remain tight.

Is Wegovy worth the cost?

The clinical data is strong. In the STEP 1 trial, participants taking semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% with placebo [5]. The STEP 5 trial showed weight loss of 15.2% maintained at 104 weeks [7]. And the SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events in people with obesity and established cardiovascular disease [6].

So the drug works. The question is whether you can afford it long enough for it to work. Most patients don’t see significant results until 3-4 months in, and the full dose titration schedule takes about 16 weeks.

If you have commercial insurance that covers Wegovy, the $25/month savings card makes this a straightforward choice. If you’re paying out of pocket and $349/month through NovoCare is manageable, that’s the next best option.

If neither works, compounded semaglutide at $149-$299 per month through a reputable telehealth provider offers the same active ingredient at a fraction of the cost. You can check if you qualify for treatment here.

Other ways to reduce Wegovy costs

Patient assistance programs

Novo Nordisk offers a Patient Assistance Program (PAP) for uninsured patients who meet income requirements. Eligibility typically requires household income below 400% of the federal poverty level. If you qualify, you may receive Wegovy at no cost. Apply through NovoCare.com.

Insurance appeals

If your insurance denied Wegovy coverage, you can appeal. A letter of medical necessity from your prescriber documenting BMI, comorbidities (especially cardiovascular risk), and failed attempts at other weight loss interventions strengthens your case. The 2024 cardiovascular indication gives providers additional justification to argue for coverage.

Flexible spending accounts (FSA/HSA)

Wegovy qualifies as an eligible expense for FSA and HSA accounts when prescribed for a medical condition. This won’t reduce the price, but paying with pre-tax dollars effectively saves you 20-35% depending on your tax bracket.

Switching to the oral formulation

The Wegovy pill (oral semaglutide 25 mg) launched in January 2026. In some cases, the oral formulation has different pricing through discount programs. GoodRx lists introductory pricing at $149 per month for certain doses. If you’re flexible on delivery method, ask your provider about the tablet option.

Frequently asked questions

How much does Wegovy cost per month without insurance?▼

The list price is approximately $1,350 for a 28-day supply. Through Novo Nordisk’s NovoCare Pharmacy, uninsured patients can access Wegovy for $349 per month after an introductory period of $199 per month for the first two fills on starter doses. Pharmacy discount cards like GoodRx offer similar pricing.

Can I get Wegovy for $25 a month?▼

Only if you have commercial health insurance that covers Wegovy. The Novo Nordisk savings card reduces your copay to as little as $25 per month, with maximum savings of $100 per fill [3]. Patients with Medicare, Medicaid, or Tricare are excluded from this offer.

Is there a generic version of Wegovy?▼

No. Semaglutide remains under patent protection, and no FDA-approved generic exists as of April 2026. Compounded semaglutide is available through licensed pharmacies but is not the same as a generic medication.

What is the cheapest way to get semaglutide?▼

Compounded semaglutide through a licensed telehealth provider typically costs $149-$299 per month, making it the most affordable legitimate option. This usually includes the prescriber consultation, medication, and injection supplies. For brand-name Wegovy specifically, the NovoCare Pharmacy self-pay program at $349/month is the lowest price without insurance.

Is compounded semaglutide the same as Wegovy?▼

The active ingredient is the same molecule, but compounded semaglutide is not FDA-approved as a finished product. It’s prepared by compounding pharmacies rather than manufactured by Novo Nordisk. Quality varies by pharmacy, and 503B outsourcing facilities generally face more regulatory oversight than 503A pharmacies. See our compounded semaglutide safety guide for more detail.

Does Medicare cover Wegovy?▼

Medicare Part D began limited coverage of Wegovy in 2026, primarily for patients with the cardiovascular indication (reducing risk of heart attack and stroke in adults with obesity and established heart disease). Coverage for the weight management indication alone remains limited. You cannot use the Novo Nordisk savings card with Medicare.

How long do I need to take Wegovy?▼

Wegovy is intended for long-term use. The STEP 1 extension study showed that participants regained approximately two-thirds of lost weight within one year of discontinuing treatment [2]. Most prescribers recommend continued use as long as the medication remains effective and tolerable.

Can I switch between Wegovy and compounded semaglutide?▼

Yes, with provider guidance. Since both contain semaglutide, switching is straightforward from a pharmacological standpoint. Your provider will adjust dosing to match your current level. Some patients start with compounded semaglutide and switch to brand-name if insurance coverage becomes available, or vice versa.

The bottom line

Wegovy’s list price of $1,350 per month puts it out of reach for many people without insurance coverage. But the actual price you’ll pay depends on which savings pathway you use.

With commercial insurance and the savings card, you could pay $25 per month. Without insurance, NovoCare Pharmacy and GoodRx bring the cost to $349 per month after introductory pricing. And compounded semaglutide through a licensed telehealth provider runs $149-$299 per month.

The STEP clinical trials consistently show 14-15% body weight reduction over 68 weeks with semaglutide 2.4 mg [5]. The SELECT trial added cardiovascular protection to the evidence base [6]. The medication works. The barrier is cost, and in 2026, there are more options than ever to bring that cost down.

If you’re ready to explore your options, you can find out if you qualify for GLP-1 treatment through our telehealth program.

References

1. GoodRx. “How Much Does Wegovy (Semaglutide) Cost Without Insurance?” Updated January 22, 2026. goodrx.com/wegovy

2. Wilding JPH, et al. “Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.” Diabetes Obes Metab. 2022;24(8):1553-1564. PubMed

3. Novo Nordisk. “Wegovy Savings Card, Cost & Coverage Support.” wegovy.com

4. FDA. “Compounded Drugs: FDA’s Role and Risks.” fda.gov

5. Wilding JPH, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” N Engl J Med. 2021;384(11):989-1002. PubMed

6. Lincoff AM, et al. “Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.” N Engl J Med. 2023;389(24):2221-2232. PubMed

7. Garvey WT, et al. “Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5.” Obesity. 2023;31(3):703-715. PubMed